---
edited: 2024-03-02
tags:
  - Pharmacology
---
### ADRs
- [[SJS & TEN (Epidermal necrolysis)]]
	- When high doses are used, risk is highest
	- Initial dose should be low and increased slowly
- 10% patients develop rash which is difficult to differentiate from early SJS (patients should be advised to discontinue at the first sign of a rash)

---
